Lykiri, thank you for sharing this video. Evidently, in the UK, there is a real-time logistical direct link, through the Autolomous software platform, between the NHS, Advent, the hospitals, the clinicians who treat cancer patients, and the patients.
A clinician will be able to order DCVax-L on behalf of their patient, and the order would be tracked all the way through the process, including: cell / tissue/ blood materials obtained from the patient, the materials arriving at Advent, the material processed into DCVax-L, the initial vaccine dose being sent back to the hospital, and finally the DCVax-L vaccine being injected back into the patient.
Subsequent DCVax-L doses needed for each patient will be stored at Advent until they are needed to be injected into the patient.
Bullish
News 
Market Data 
Discover 
